Results 61 to 70 of about 170,023 (183)

Safety, Biodistribution, and Efficacy of an AAV-5 Vector Encoding Human Interferon-Beta (ART-I02) Delivered via Intra-Articular Injection in Rhesus Monkeys with Collagen-Induced Arthritis [PDF]

, 2015
Lisette Bevaart, Caroline Aalbers, Michel Vierboom, Niels Broekstra, Ivanela Kondova, Elia Breedveld, Bernd Hauck, J. Fraser Wright, Paul P. Tak, Margriet J. Vervoordeldonk   +9 more
openalex   +1 more source

PHARMACOGENETICS OF INTERFERON BETA IN MULTIPLE SCLEROSIS

IBRO Neuroscience Reports, 2023
Mohamed Rayen Ganouni, Malek Jemni, Yassine Khalij, Bissene Douma, Sana Boujaafer, Dorra Amor, Salma Naija, Asma Asma, Sana Amor, Ali Bouslama   +9 more
doaj   +1 more source

The influence of genetic variants of IL-6 (-174 G/C) and INFγ (+ 874 A/T) and their impact on anemic Sudanese children with kidney failure

BMC Research Notes
Objectives To investigate the influence of genetic variants IL-6 (-174 G/C) and interferon-gamma (IFNγ) (+ 874 A/T) on beta-globin gene expression, inflammation markers such as C-reactive protein (CRP), and their diagnostic impact on anemic Sudanese ...
Abier Abdelaziz Makkawi Abdelrahman Makkawi, Salah Eldin GumaaElzaki GumaaElzaki, Nahla Allam Allam, Nadia Madani Mohammed Ahmed Mohammed, Nazik Elmalaika Obaid Seid Ahmed Husain Husain   +4 more
doaj   +1 more source

Methylprednisolone, Mycophenolate Mofetil, or Cyclophosphamide as Combination Therapy With Interferon Beta-1a in Patients With Multiple Sclerosis: Retrospective Study [PDF]

, 2007
William H. Stuart, Jeffrey English, Donna Court, John D. Warth, Steven Yawn   +4 more
openalex   +1 more source

PNR1: COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF INTERFERON BETA-IB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN POLAND (2-YEARS PERSPECTIVE)

, 2000
Ewa Orlewska, Paweł Mierzejewski, Anna Członkowska   +2 more
openalex   +1 more source

A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans. [PDF]

, 1990
Joan H. Schiller, B. Storer, Donna M. Paulnock, R. R. Brown, S. P. Datta, Patricia L. Witt, Ernest C. Borden   +6 more
openalex   +1 more source

Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b

Patient Preference and Adherence, 2015
Ivonne Weller,1 Anna Saake,1 Thomas Schreiner,1 Julika Vogelreuter,1 Nicolas Petroff2 1Bayer Vital GmbH, Leverkusen, Germany; 2Vitartis Medizin-Service GmbH, Göttingen, Germany Purpose: Multiple sclerosis (MS) is a chronic demyelinating ...
Weller I, Saake A, Schreiner T, Vogelreuter J, Petroff N   +4 more
doaj  

Clinical characteristics, treatments, and outcomes of interferon-beta-induced thrombotic microangiopathy: a literature-based retrospective analysis. [PDF]

Ther Adv Neurol Disord, 2023
Wang C, Fang W, Sun W, Zhao S, Peng L.
europepmc   +1 more source

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy

, 2016
Damiano Paolicelli, Sergio Iannazzo, Laura Santoni, Antonio Iaffaldano, Valentina Di Lecce, Alessia Manni, Vito Lavolpe, Carla Tortorella, Mariangela D’Onghia, Vita Direnzo, Elisa Puma, María Trojano   +11 more
openalex   +2 more sources

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis. [PDF]

Front Immunol, 2023
Xavier A, Campagna MP, Maltby VE, Kilpatrick T, Taylor BV, Butzkueven H, Ponsonby AL, Scott RJ, Jokubaitis VG, Lea RA, Lechner-Scott J.   +10 more
europepmc   +1 more source